About us
IP CURE B
IP-cure-B is a five-year project started in January 2020, coordinated by INSERM in France.
Our collaborative network brings together 13 complementary partners, including 10 research institutions, 1 pharmaceutical company, 1 patient association and 1 private company from 9 different countries (including 8 European member states).
IP Cure B
Our Project
Video
Check the new IP-Cure-B Myth Busters Videos
Prof Dr Maria Buti, MD IP cure B Principal Investigator
Prof Dr Pietro Lampertico, MD IP cure B Principal Investigator
Prof Dr Massimo Levrero, MD IP cure B Principal Investigator
Prof Dr Maria Buti, MD - IP-cure-B Principal Investigator
Prof Dr Gabriele Missale, MD IP cure B Principal Investigator
Prof Dr Massimo Levrero, MD IP cure B Principal Investigator
Prof Dr Linda Wittkop, MD IP cure B Principal Investigator
Prof Dr Fabien Zoulim, MD IP cure B Principal Investigator
Prof Dr Fabien Zoulim, MD IP cure B Principal Investigator
Prof Dr Massimo Levrero, MD IP cure B Principal Investigator
Dr Hélène Strick Marchand, PhD IP cure B Principal Investigator
Prof Dr Maria Buti, MD IP cure B Principal Investigator
Prof Dr Gabriele Missale, MD IP cure B Principal Investigator
Dr Hélène Strick Marchand, PhD IP cure B Principal Investigator
Prof Dr Pietro Lampertico, MD IP cure B Principal Investigator
Video
Hear from the principal investigators
Maria Buti
Susanna Tan
Carlo Ferrari
Fabien Zoulim
Massimo Levrero
Pietro Lampertico
Hélène Strick-Marchand
Marko Korenjak
News